To determine the impact of radical node dissection on the recurrence patterns and survival rates of patients with carcinoma of the esophagus.
Objective
To determine the impact of radical node dissection on the recurrence patterns and survival rates of patients with carcinoma of the esophagus.
Summary Background Data
The role of esophagectomy with radical lymphadenectomy in the treatment of esophageal cancer is controversial. Most centers favor a limited operation with no attempt at nodal clearance. However, disease recurrence and patient survival rates remain dismal with or without preoperative therapy. The authors postulate that a more radical node dissection would reduce local failure rates and enhance survival.
Methods
One hundred eleven patients with esophageal cancer underwent en bloc esophagectomy with radical lymph node dissection between 1988 and 1998. In 90% of patients the proce-dure was applied nonselectively and without any preoperative therapy. Patients were prospectively followed up for recurrence patterns and survival.
Results
The 5-year survival rate including noncancer deaths was 40%. The 5-year survival rates for patients with stage 1, 2A, 2B, 3, and 4 disease were 78%, 72%, 0%, 39%, and 27%, respectively. Forty percent of patients had node-negative disease (5- year survival rate, 75%), and 60% had nodal metastases (5- year survival rate, 26%). Recurrence occurred in 39% of patients and was local in only 8%.
Conclusions
Radical esophagectomy results in superior overall and stagespecific 5-year survival rates. Extensive node dissection has a positive impact on survival rates, particularly in patients with nodal metastases.
The treatment of patients with cancer of the esophagus remains controversial. The therapeutic options are varied and include primary surgical resection, surgical resection after preoperative chemotherapy, chemoradiotherapy, or nonsurgical treatment using definitive chemoradiation. The latter method seems to be gaining appeal among radiation and medical oncologists, given the generally unfavorable outcomes after surgical resection or preoperative combined modality therapy. However, in nearly all reports of surgical resection, esophagectomy had been performed with a limited nodal dissection in the abdomen or mediastinum. In fact, with some resection techniques, the extent of mediastinal nodal clearance is negligible. Therefore, it is not surprising that the local recurrence rates reported after standard resection techniques are in the range of 20% to 60%. 1 Because an R0 resection (no gross or microscopic residual disease) seems to be a key determinant of outcome, we postulate that a more radical approach to nodal clearance may enhance survival. The current study was designed to evaluate the impact of en bloc esophagectomy combined with radical two-field or three-field lymphadenectomy on the local recurrence and survival rates of patients with cancer of the esophagus.
METHODS
Between January 1988 and December 1998, 163 patients underwent esophagectomies for esophageal cancer at our institution. This report is a descriptive analysis of a total of 111 patients (102 consecutive patients) who underwent en bloc esophagectomy with radical lymph node dissection of at least two fields (abdomen and mediastinum). Throughout the first 4 years of this study (1988 -1992) , we used a selection strategy involving preoperative and intraoperative staging to select patients with early-stage disease (stage 1 and 2) for en bloc resection with radical mediastinal and abdominal lymphadenectomy. During that early period, only nine patients underwent en bloc resection (8% of the current series), mainly because of a prevailing surgical bias in favor of limited resections. Those with more advanced disease underwent a standard transthoracic esophagectomy with lymph node dissection limited to the periesophageal and perigastric nodes. During the same period (1988 -1992) , 50 patients underwent a "standard" esophagectomy. Since August 1992, our surgical policy has been to perform an en bloc resection with a radical two-field or three-field lymphadenectomy in all patients, provided there was no evidence of visceral metastases or locally unresectable disease (T4 tumors). One hundred two consecutive patients underwent en bloc resection between August 1992 and December 1998.
Preoperative Evaluation
Initial evaluation included an upper endoscopy with biopsy and computed tomography of the chest and upper abdomen in all patients. More recently we have included endoscopic ultrasonography and positron emission tomography scanning to the staging workup. Patients were considered for surgical resection if preoperative evaluation revealed no evidence of distant visceral metastases or clear evidence of direct neoplastic invasion of the airway or major vascular invasion. All patients underwent evaluation of pulmonary and cardiac function to determine their ability to withstand the planned procedure. Generally, patients with a forced expiratory volume in 1 second of less than 1.5 L/s, despite aggressive physiotherapy and bronchodilator therapy, were considered ineligible for resections. Cardiac disease, if suspected, was carefully assessed using noninvasive means or angiocardiography if necessary.
Adjuvant Therapy
It had been our strategy not to use preoperative therapy of any kind before resection. However, 11 patients (10%) were referred for resection after preoperative induction therapy. Cis-platinum-based chemotherapy was used in nine patients and preoperative chemoradiation in two. Resection was carried out in 100 patients (90%) without induction therapy. Among the latter group, 70 patients received no postoperative adjuvant therapy (43 with node-negative disease and 27 with nodal metastases). Thirty patients with nodal metastases received postoperative chemotherapy at the recommendation of their medical oncologists. Postoperative radiotherapy was given in only two patients.
Surgical Procedures
The basic principle of the en bloc procedure is to resect the tumor-bearing esophagus within an envelope of adjoining tissues that includes both pleural surfaces laterally, the pericardium anteriorly (in all but T1a lesions), and the lymphovascular tissues wedged dorsally between the esophagus and the spine. In addition, the thoracic duct is resected en bloc with the specimen throughout its course in the posterior mediastinum. 2 In a minor modification of the previously published technique, the intercostal vessels and the trunk of the azygous vein are spared, but the azygous arch is resected en bloc with the esophagus. In addition, for tumors traversing the esophageal hiatus, a 1-inch cuff of diaphragm is resected circumferentially around the tumor. As described, the en bloc procedure necessarily includes a complete dissection of the middle and lower mediastinal nodes, including the periesophageal, parahiatal, subcarinal, and aortopulmonary window lymph nodes. In addition, an upper abdominal and retroperitoneal node dissection is performed, including resection of the celiac, splenic, common hepatic, left gastric, lesser curvature, and parahiatal nodes. The spleen is routinely preserved. The previously described two-field lymphadenectomy was carried out in 51 patients. In the remaining 60 patients (since 1994), a third field was added to the procedure. In addition to a mediastinal and abdominal lymphadenectomy, dissection included the nodes in the superior mediastinum located along the right and left recurrent nerves throughout their mediastinal course. The left recurrent nerve was exposed throughout its course in the superior mediastinum from the level of the aortic arch to the thoracic inlet. The nerve was dissected using a "notouch" technique, and the nodes along its anterior aspect were carefully excised. In nearly all whites there is a remarkable paucity of nodal tissue along the left recurrent nerve. The right recurrent nerve was carefully exposed near its origin at the base of the right subclavian artery. The right recurrent nodal chain begins at that level and forms a continuous package that extends through the thoracic inlet into the neck. Again the nerve is dissected using a strict "no-touch" technique. Using a cervical incision, the remainder of the recurrent laryngeal nodes were dissected as well as the lower deep cervical nodes located medial and lateral to the carotid sheath. Reconstruction was achieved using a greater curvature gastric tube (n ϭ 101) or an isoperistaltic segment of the left colon (n ϭ 10). The anastomosis was performed in the neck in 101 patients and in the mediastinum in 10.
Follow-Up
After hospital discharge, patients were seen at intervals of 3 months for the first 2 years and every 6 months thereafter. Patients from distant geographic locations were followed up by contacting their treating physician, as well as direct patient contact. Computed tomography of the chest and upper abdomen and upper endoscopy were performed yearly, but other studies were done only in symptomatic patients. All data were collected and entered prospectively into a database and updated at regular intervals. Complete follow-up information until death or September 2000 was available for all patients.
Recurrence
Local recurrence was defined as recurrence at the anastomosis or at any site in the surgical field. This definition encompassed both local and locoregional failures. Recurrent disease (either local or distant) was histologically confirmed whenever possible.
Statistical Analysis
Survival time was measured from the time of the procedure until death (including surgical deaths and noncancerrelated deaths) or September 2000. Survival distribution was estimated by the product limit method and compared by the log-rank test. Level of significance for all tests was P Ͻ .05.
RESULTS

Hospital Deaths
The overall hospital mortality was 5.4%, with six inhospital deaths (30-day mortality, 3.6%). The causes of hospital death included pulmonary emboli in two patients, sepsis with multisystem organ failure in two patients, drugresistant Pseudomonas pneumonia in one patient, and a massive stroke in one patient.
Surgical Morbidity
Fifty-seven patients (51%) had an uncomplicated postoperative course. Complications occurred in 54 patients and were considered minor in 11 and major in 43 (including 6 postoperative deaths) (38.7%) ( Table 1 ). The most common complication was pulmonary. Anastomotic leaks developed in 15 patients. Recurrent nerve injuries occurred in only four patients and were unilateral in all. No patients required tracheostomy as a result of recurrent nerve injury.
Clinicopathologic Characteristics
Most patients were men, with a median age of 60 years (range 34 -81). Squamous cell carcinoma was present in 30 patients. Adenocarcinoma was present in 81 patients, of whom 69 had histologic evidence of associated intestinal metaplasia. Staging was based on the TNM staging system of the American Joint Commission on Cancer (1987) and is shown in Table 2 . The median number of resected nodes was 36 nodes per patient (range 5-107). Forty-three patients had node-negative disease, whereas nodal metastasis was present in 68 patients (60%). En Bloc Esophagectomy
Survival
The 5-year survival rate, including surgical deaths and noncancer-related deaths, was 40%, with a median survival of 38 months (Fig. 1) . Survival was not influenced by either cell type or tumor location. There was no difference in overall survival distribution or median survival times between patients who underwent a two-field dissection and those treated by a three-field lymphadenectomy (Fig. 2) . Patients with stage 1 and 2A had 5-year survival rates of 78% and 72%, respectively (median not reached). There were no 5-year survivors among 10 patients with stage 2B disease (median 30 months). Thirty-six patients had stage 3 disease and 23 had stage 4 tumors (celiac or recurrent laryngeal positive nodes). The 5-year survival rates were 39% for stage 3 patients (median 53 months) and 27% for stage 4 patients (median 20 months).
Node-negative patients had a 5-year survival rate of 75% (median not reached) ( Fig. 3 ). In the presence of nodepositive disease, the 5-year survival rate was 26% (median 30 months). When patients with positive nodes were segregated arbitrarily into an N1 group (locoregional nodes) and an N2 group (distant M1a nodes), survival was significantly better in patients with locoregional nodal metastases (31% vs. 21%, P ϭ .03) ( Fig. 4) .
In the presence of nodal metastases, the number of positive nodes was an important determinant of survival only if the number of nodal metastases exceeded five positive nodes. Patients with six or more nodes had a worse prognosis compared with those with five or fewer positive nodes (P ϭ .056). This difference became highly significant when patients with seven positive nodes were compared with those with up to six positive nodes (P ϭ .0002) ( Fig. 5 ). Sixteen of 68 patients with nodal metastasis survived at least 3 years. Thirteen are alive without recurrent disease, two are alive with stable distant recurrences, and one died after 4 years with metastatic lung cancer. The number of positive nodes in each of these 16 patients is shown in Table 3 . 
Impact of Adjuvant Therapy
Postoperative therapy was not given to any patient with node-negative disease except one patient who had tumor invading the diaphragm (T4N0). There was no significant difference in overall survival estimates or median survival times between node-positive patients who received postoperative chemotherapy (n ϭ 30) and those who did not (n ϭ 27) ( Fig. 6) .
Recurrence
At the time of this report, 68 patients (61%) are alive without recurrence. Distant metastasis developed in 31 patients (28%), local recurrences in 5 (4.5%), and both distant and local recurrences in 4 (3.6%). Overall local recurrence (anastomotic, mediastinal or upper abdominal) occurred in nine patients (8%). Three patients (2.7%) had an incomplete resection (R1 or R2).
DISCUSSION
Although esophagectomy remains the standard of care for patients with esophageal cancer, its role has recently been challenged. Five-year survival rates in most modern series ( Table 4 ) rarely exceed 30%, even in patients in whom a potentially curative resection is performed (R0 resection). [3] [4] [5] [6] [7] [8] [9] [10] [11] These survival rates are essentially identical to those achieved with nonsurgical therapy using combined chemoradiation. 12 In addition, local recurrence rates remain unacceptably high after either standard surgical resection (20 -60%) or primary chemoradiation (44%), suggesting that neither modality can control local disease. 1, 12 We believe that our data suggest that en bloc esophagectomy may be a reasonable alternative treatment strategy for patients with esophageal cancer. This view is based on several key points highlighted by our data.
First, the procedure can be performed with a death rate identical to that of more limited resections. Our experience is not unique in this regard: similar results have been reported by several centers that advocate a similar strategy. 13, 14 Nonetheless, despite the gratifyingly low hospital death rates, esophagectomy remains a formidable surgical procedure with a substantial complication rate. In the current series the complication rate was almost 50%, with 38% of patients having a major complication that was fatal in six. This complication rate is in the range reported in several series of more limited resections (see Table 4 ). [3] [4] [5] [6] [7] [8] [9] [10] [11] A recent report on esophageal cancer initiated by the Commission on Cancer of the American College of Surgeons found that major complications occurred in 46% of 1,100 patients with esophageal cancer treated by primary surgical resection in the United States in 1994. 15 In the current series, as in others, pulmonary complications were the most common, followed by leakage at the anastomoses. The latter occurred in 15% of our patients and was fatal in none. This leak rate is not dissimilar from that generally expected after a cervical esophagogastric reconstruction. In a recent large series of 800 patients treated by transhiatal esophagectomy, the anastomotic leak rate was almost 14%. 4 Second, our 5-year disease-free survival rate of 40% far exceeds that reported after more limited resections. These data represent the outcome after surgical resection alone, because only 10% of patients received induction therapy. However, all retrospective studies such as the current one En Bloc Esophagectomy are subject to several limitations. For example, one cannot reasonably exclude the possibility of a prereferral selection bias. In addition, referred patients who had visceral metastases detected before or during surgery did not undergo resection. Similarly, when T4 disease was confirmed before surgery (by endoscopic ultrasonography) or encountered early in the surgical procedure, resection was abandoned. Thus, only three patients in this series had T4 disease. Two had tumors invading the membranous trachea and one had tumor invading the diaphragm; in this patient, an R0 resection was accomplished. Beyond these two selection criteria, the procedure was applied without preoperative or intraoperative selection bias in nearly 90% of patients. Nodepositive disease was present in 60% of our patients, a distribution similar to that in other reported series (see Table  4 ). It thus appears that patient selection biases may not be any more prevalent in this series than in others reported in the literature. Third, although nodal metastases are undoubtedly markers of poor outcome, cure may be possible in a significant minority of patients (25% in this report) with surgical resection alone. In the group of patients with positive nodes, several factors seem to predict a more favorable outcome. Patients with locoregional nodes fared significantly better than those with distant positive nodes at the celiac or recurrent laryngeal nodes. Nonetheless, even in this latter group, 27% of patients were long-term survivors, suggesting that this group should not be considered as stage 4 but rather as a subgroup of stage 3.
The number of positive nodes was another important determinant of survival. Several investigators have made similar observations, with variation in the absolute number of positive nodes separating survivors from nonsurvivors. 5, 16, 17 In this report the presence of seven or more positive nodes, as previously suggested by Akiyama et al, 16 predicted the worst prognosis. However, despite the relative importance of the number of positive nodes, it is nearly impossible to predict with certainty who among node-positive patients will achieve long-term survival. As shown in Table 3 , 5 of 16 node-positive patients who survived at least 3 years had six or more nodal metastases. One patient who had 10 positive nodes is alive and well 4 years after surgery.
Finally, the local/locoregional recurrence rate in this series was only 8%. This is lower than local failure rates reported after more limited resections or nonsurgical therapy. 1,18 -20 All patients with local recurrence died of their disease, a testament to the uniformly fatal outcome of this event. It is improbable that the value of induction therapy can be fairly assessed when measures of local disease control are inadequate.
We have previously reported the superior survival achieved by en bloc resection with two-field lymphadenectomy compared with survival results after the more standard esophagectomy technique. 21 Since mid-1994, we extended our dissection to include the superior mediastinal and cervical node (three-field lymphadenectomy) in patients with esophageal carcinoma, regardless of cell type or location in the esophagus. Extending the dissection to those areas detected nodal metastases to the cervical region in almost 30% of patients with squamous carcinoma or adenocarcinoma, including lower-third tumors. However, with a median follow-up of 44 months in the two-field group and 30 months in the three-field group, there appears to be no statistically significant difference in overall survival. Because long-term survival is achieved in only 25% of patients with positive neck nodes, a significant survival advantage for the threefield procedure may become apparent only with a larger sample size.
Should en bloc esophagectomy be the standard of care for esophageal carcinoma? We believe that the results of this study may encourage studies in other centers to validate the technique and the reproducibility of its results. Eventually, a multiinstitutional randomized trial may be required to determine its efficacy. Undoubtedly, however, the procedure is technically demanding and time-consuming: the average operating time is 7 hours. Postoperative care is tedious and requires attention to detail, particularly with regard to pulmonary care. These intraoperative and postop- erative considerations will probably restrict application of the procedure to specialized esophageal centers.
